A Health Belief Model Based Intervention to Increase Human Papilloma Virus (HPV) Vaccination Among College Men
Designing and Evaluating a Health Belief Model Based Intervention to Increase Intent of HPV Vaccination Among College Men: Use of Qualitative and Quantitative Methodologies
2 other identifiers
interventional
90
1 country
1
Brief Summary
The purposes of this study are to (1) identify predictors of Human papillomavirus (HPV) vaccine acceptability among college men based on the Health Belief Model through focus groups, (2) triangulate focus group results with a prior quantitative study in developing an intervention based on the Health Belief Model to enhance HPV vaccine acceptability, and (3) test the efficacy of the above intervention based on the Health Belief Model by comparing it to a knowledge-based intervention. Approximately five focus groups with ten participants in each group with college students in the ages 18-25 years will be conducted at a large Midwestern University for the qualitative piece. Data will be analyzed for categories and triangulated with previous study to develop a theory based intervention. For the quantitative piece a randomized controlled design with 45 participants in each arm (theory based intervention and knowledge based intervention) will be implemented.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_4
Started Sep 2011
Shorter than P25 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2011
CompletedFirst Submitted
Initial submission to the registry
September 3, 2011
CompletedFirst Posted
Study publicly available on registry
September 9, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2012
CompletedResults Posted
Study results publicly available
December 10, 2012
CompletedFebruary 4, 2013
January 1, 2013
10 months
September 3, 2011
September 30, 2012
January 30, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change From Baseline to Post Intervention to Follow-up (up to 3 Months) After the Interventions the Number of Participants Who Have Taken the HPV Vaccine
Before, after and one to three month following the health belief model based educational intervention and knowledge-based educational intervention the participants will be asked if they have taken the first dose of HPV vaccine and changes noted.
Post intervention and up to 3 months after the interventions
Change From Baseline to Post Intervention to Follow-up up to 3 Months After the Interventions the Number of Participants Who Intend to Take HPV Vaccine Using HPV Intent Scale (Possible Range 0-4 Likert Units)
Before the interventions, post test after the interventions and follow-up 1 to 3 months after the interventions (health belief model based and knowledge based) participants will be asked about their intent to take the HPV vaccine on a scale of 0-4 Likert units and changes noted. Posttest was conducted immediately after the intervention. Minimum score = 0 indicating no intent to take vaccine; Maximum score = 4 indicating strong intent to take vaccine. Scale was a single item scale.
Post intervention and up to 3 months after the intervention
Secondary Outcomes (6)
Change From Baseline to Post Intervention to Follow-up (up to 3 Months) After the Interventions in Score of Perceived Susceptibility for HPV
Post interventions and up to 3 months after the interventions
Change From Baseline to Post Test to Upto 3 Month Follow-up After the Interventions in Score for Perceived Severity for HPV
Post interventions and up to 3 months after the intervention
Change From Baseline to Post Test After the Interventions to up to 3 Month Follow-up in Score of Perceived Benefits of HPV Vaccine
post intervention and up to 3 months after the interventions
Change From Baseline to Post Test After the Interventions to Follow-up (up to 3 Months) in the Score of Perceived Barriers to Receiving HPV Vaccine
post interventions and up to 3 months after the intervention
Change From Baseline to After the Interventions to Follow-up up to 3 Months After the Interventions in Score of Cues to Action to Receiving HPV Vaccine
Post interventions and up to three months after the intervention
- +1 more secondary outcomes
Study Arms (2)
Health belief model based education
EXPERIMENTALThis experimental arm will provide an educational intervention designed to modify constructs of health belief model regarding HPV vaccine acceptability.
Knowledge-based education
ACTIVE COMPARATORThis comparison arm will provide education based on knowledge regarding HPV vaccine acceptability.
Interventions
One arm will receive health belief model based educational intervention and other arm will receive knowledge-based educational intervention.
Eligibility Criteria
You may qualify if:
- Males
- English speaking
- years
- Undergraduate or graduate student at the University of Cincinnati
You may not qualify if:
- Females
- Under 18 years, or above 25 years
- Non- English speaking individuals
- Non-university attending students
- If already received HPV vaccination
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Manoj Sharma
Cincinnati, Ohio, 45221-0068, United States
Related Links
Limitations and Caveats
Overall limitation of the trial were due to attrition at the one month follow up. This was due to the end of school year.This meant that students were busy preparing for finals, starting co-ops/internships, moving back home, or lack of interest.
Results Point of Contact
- Title
- Dr. Manoj Sharma, PI
- Organization
- University of Cincinnati
Study Officials
- PRINCIPAL INVESTIGATOR
Manoj Sharma, Ph.D.
University of Cincinnati
- STUDY DIRECTOR
Rebecca Lee, Ph.D.
University of Cincinnati
- STUDY DIRECTOR
Purvi Mehta, MS
University of Cincinnati
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- LTE60
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
September 3, 2011
First Posted
September 9, 2011
Study Start
September 1, 2011
Primary Completion
July 1, 2012
Study Completion
August 1, 2012
Last Updated
February 4, 2013
Results First Posted
December 10, 2012
Record last verified: 2013-01